Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.010
-0.030 (-2.88%)
At close: May 12, 2025, 4:00 PM
0.9730
-0.0370 (-3.66%)
After-hours: May 12, 2025, 4:05 PM EDT
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $40.26 million as of May 12, 2025. Its market cap has decreased by -46.28% in one year.
Market Cap
40.26M
Enterprise Value
25.26M
1-Year Change
-46.28%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $40.26M, a decrease of -75.28%. That is a compound annual growth rate of -29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 42.73M | -1.93% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |